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Summary 
The patterns of cytokine mRNA expression in mice with primary or secondary influenza pneumonia 
have been assessed by in situ hybridization analysis of cells from both the mediastinal lymph 
node (MLN) and the virus-infected lung. Evidence of substantial transcriptional activity was 
found in all lymphocyte subsets recovered from both anatomical sites. The kinetics of cytokine 
mRNA expression after primary infection with an H3N2 virus were in accord with the idea 
that the initial response occurs in regional lymphoid tissue, with the effector T cells later moving 
to the lung. This temporal separation was much less apparent for the more rapid secondary response 
resulting from challenge of H3N2-primed mice with an H1N1 virus. Among the T ceU receptor 
c~/B + subsets,  transcripts for interferon (IFN) "y and tumor necrosis factor ~ were most com- 
monly found in the CD8 + population whereas mRNA for interleukin (IL) 4 and IL-10 was 
much more prevalent  in CD4 + T  ceils. The "y//~ T  cells expressed  mRNA for all cytokines 
tested, with IL-2, IL-4, and IFN-3/predominating among those recovered from the inflammatory 
exudate.  At particular time points, especially early in the MLN and late in the infected lung, 
the frequency of mR.NA + lymphocytes was much higher than would be expected from current 
understanding of the prevalence of virus-specific precursors and effectors. If this response is typical, 
induction of cytokine gene expression for T cells that are not responding directly to the invading 
pathogen may be a prominent feature of acute virus infections. 
C 
ell-mediated immunity (CMI) 1 reflects a complex inter- 
play of events involving NK cells, APCs, T  lympho- 
cytes, and activated macrophages. Communication between 
these diverse cell types operates via surface ligands (such as 
the clonotypic TCK) that promote cell-cell interaction and 
by a spectrum of secreted factors,  the cytokines, that may 
variously induce activation, proliferation, or downregulation 
(1-4).  Rigorous analysis of the role of different cytokines in 
the in vivo situation is likely to provide key insights into the 
pathogenesis of disease processes,  and to suggest rational 
measures for control and therapy. The now classical example 
is that a response skewed towards Ib4 production leads to 
a progressive, fatal disease in BALB/c mice infected with Le/sh- 
1 Abbreviations used in this paper: BAL, bronchoalveolar lavage; CMI, cell- 
mediated immunity; H, influenza virus hemagglutinin molecule; HAU, 
hemagglutinating units; MACS, magnetic  activated cell sorter;  MLN, 
mediastinal lymph node; N, influenza virus neuraminidase molecule; NA, 
nonadherent (to plastic); i.n., intranasal; HSSC, high side, or 90  ~ scatter 
on the FACS|  LSSC, low side scatter. 
mania tropica, whereas C3H mice emphasize secretion of IFN-3, 
and clear the parasite  (5). 
The murine influenza pneumonia model is one of the better 
defined experimental systems for dissecting the complexities 
of CMI in virus infections (2, 6). It is clear that CD8 § T 
cells are normally the key mediators of virus clearance, though 
CD4 + effectors may also function with varying success de- 
pending on the virulence of the challenge virus (7-9). Little 
is known about the roles of secreted mediators in this viral 
pneumonia. Levels of various cytokines have been measured 
in  the  cell-free  bronchoalveolar lavage  (BAL)  fluid from 
BALB/c mice dying within 6 d of intranasal  (i.n.) infection 
with the A/PRS/34 (H1N1) influenza A virus, the surprising 
finding being that there was little evidence for the produc- 
tion of the lymphokines that are normally associated with 
T  lymphocyte activation (10). Perhaps this reflects the in- 
ability of cytokine bioassays to detect low levels of the product, 
or consumption of these cytokines by the various cellular ele- 
ments involved in the host response. The difficulties associated 
with assaying cytokines directly from the in vivo situation 
are avoided in the present experiments by using in situ hybrid- 
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BAL and regional mediastinal lymph nodes (MLN) cells during 
the course of both primary and secondary, nonfatal influenza 
pneumonia in C57BL/6 mice (2, 6, 7). This unique analysis 
of a disease process defines the potential for cytokine secre- 
tion by freshly isolated T  cells, though the question of the 
levels of production of these mediators is left to subsequent 
studies. 
Materials and Methods 
Mice.  The C57BL/J (B6) female  mice used in these experiments 
were purchased from the Jackson Laboratory (Bar Harbor, ME) 
and infected initially with virus at 8-10 wk of age. 
Virus Infection.  The A/HKx31 (H3N2) influenza A virus is a 
recombinant between A/PR8 (HIN1) and A/Aichi with the sur- 
face H3N2 proteins of A/Aichi and many of the internal compo- 
nents of A/PR8 (13). Virus stocks were grown in the allantoic 
cavity of  chick embryos and shown to be free of  bacteria, including 
mycoplasma, and endotoxin. Mice were infected i.n. under Avertin 
(2,2,2 tribromoethanol) anesthesia with 30/~1 of PBS containing 
240 hemagglutinating  units  (HALT) of HKx31 or 60 HALT of 
PR8,  which cause a severe (but  generally nonlethal) infection 
in B6 mice (7). 
Sampling the Mice.  Pooled  BAL cells were obtained from the 
lungs of two to eight anesthetized, virus-infected mice (7). The 
MLN were then removed and disrupted using tissue grinders, and 
the BAL population was adhered on plastic for 90 min at 37~ 
to remove  macrophages. The nonadherent (NA) BAL lymphocytes 
and MLN cells were then used to prepare paraformaldehyde-fixed 
centrifuge preparations for the in situ hybridization studies (11, 
12), with or without prior separation into different lymphocyte 
subsets (7,  14, 15). 
Hybridization Probes.  All probes used for in situ hybridization 
were eDNA fragments, consisting of sequence complementary to 
coding  sequence only, inserted into the polylinker site of the 
pGEM-3 or -4 plasmids (Promega Corp., Madison, WI) using stan- 
dard procedures. The Ib2, I1:4, and IFN-'r probes have been de- 
scribed previously (11, 12). The I1--6 probe, provided by S. Town- 
send (Genetics  Institute, Cambridge, MA) was a 612-bp PstI-BgllI 
fragment corresponding to a full-length eDNA clone. The II:10 
probe, generously  provided  by K. Moore (DNAX, Palo  Alto, CA), 
consisted of a 554-bp PstI-SacI fragment corresponding to a full- 
length eDNA clone (16). The TNF-~ probe, provided by P. Gray 
(Genentech Inc., San Francisco, CA), was a 592-bp PvulI-KpnI 
fragment corresponding to the 1,543-2,135 bp region of the gene 
(17). pGEM/cytokine eDNA constructs were linearized and sense 
and antisense 3sS-labeled RNA transcripts were synthesized using 
SP6 or T7 RNA polymerase according to the supplier's recom- 
mendations (Promega Corp.). 
In Situ Hybridization.  Cytocentrifuge preparations of mononu- 
clear cells isolated from the MLN and BAL of virus-infected mice 
were processed for hybridization in situ as previously  described (11, 
12). Coded slides were hybridized with sense and antisense probes 
in triplicate, and the number of silver grains overlaying samples 
hybridized with sense probes was used to determine the level of 
nonspecific hybridization (routinely between 1 and 3 grains per 
cell) and to identify "cytokine mRNA +'' cells in samples hybrid- 
ized with antisense  probes. From each coded slide, over 1,000 posi- 
tive cells from at least 10 different fields  were examined to provide 
the frequency of positive cells per slide. 
Lymphocyte Separation and Phenotyping.  Pooled  lymphocyte  popu- 
lations were sorted on a FACStar Plus  |  (Becton Dickinson & Co., 
Mountain View, CA) in two-color mode (14, 15). The mAbs used 
for staining were the H57.597 anti-a/B-TCR (18), GL3 anti-34~- 
TCR (19), 53.6.7 anti-CD8 (20), and RM-4-5 anti-CD4 (21). Strep- 
tavidin RED 613 (Gibco BRL, Gaithersburg, MD) was used as 
a second step reagent. Biotinylated  mAbs and H57.597-PE, 53.6.7- 
FITC, and RM-4-5-FITC were purchased from Pharmingen (San 
Diego, CA). 
The magnetic activated cell sorter (MACS) was used with bi- 
otinylated magnetic beads as described previously (14), according 
to the protocol provided with the instrument by the manufacturer 
(Mihenyi Biotec, Sunnyvale,  CA). Lymphocytes  were separated by 
plastic adherence, then incubated with the H129.19 mAb to CD4, 
or the 53.6.72 mAb to CD8 (20). This was followed  by a biotinyhted 
goat anti-rat Ig (Southern Biotechnology  Associates, Birmingham, 
AL), then streptavidin-FITC  (Amersham  International, Amersham, 
Bucks, UK) and the biotinylated magnetic beads (Mihenyi Biotec). 
Results 
The patterns of cellular accumulation in the MLN and NA 
BAL for naive mice infected i.n. with the HKx31 (H3N2) 
virus, and for recovered HKx31-primed mice that were later 
challenged with the PR8 (H1N1) virus are shown as solid 
lines in Figs.  1 and 2. The secondary kinetics apparent for 
the BAL from the H1N1-H3N2  group on day 5 (compare 
Figs. 1 B and 2 B) reflects that many of the peptide epitopes 
recognized by both CD4 + and CD8 + T  cells are derived 
from internal proteins common to these two viruses (22-24). 
The consequence is that the virus is eliminated from the lung 
on day 5 or 6, rather than on day 7 or 8 (24). Previous studies 
have shown that the predominant surface TCR + BAL lym- 
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Cell counts per mouse (x  105, solid lines) and cytokine 
mRNA profiles  (%, as histograms)  are shown  for MLN (A) and NA BAL 
(B) populations  after  primary  infection  of B6 mice with 640 HAU of the 
HKx31 influenza  A virus. 
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* Day 0 is day 56 after the primary infection 
Cell counts per mouse  (x 
100 
50  o 
8  0 
40 
2~ 
0 
20 
10  s,  solid lines)  and cytokine 
mRNA profiles (%, as histograms) are shown for MLN (.4) and NA BAL 
(B) populations from HKx31 (H3N2)-primed  mice that were challenged 
i.n. 8 wk later with 60 HAU of the PK8 (H1N1) virus. 
Table  1.  Distribution  of mRNA in FACSO-separated  e~/fl and y/d 
TCR § BAL Lyraphocytes 
Primary  Secondary 
Day 7 
Day 10 H3N2  H1NI~H3N2 
mRNA  s/B §  y/~  ~/~+  y/h* 
IL-2  24*  45  31  12 
IL-4  16  32  13  29 
IL-6  11  18  17  6 
IL-10  9  27  6  15 
IFN-3'  21  49  21  39 
TNF-/5  10  27  18  24 
TCR Cot  71  11  67  NT 
TCR Ct~  9  85  6  57 
The cells were separated in two-color mode using H57-597-PE and bio- 
tinylated GL3 plus streptavidin-FITC. 
* Results are expressed as percent mRNA cells  for nonadherent BAL popu- 
lations. 
phocytes in both the primary and secondary responses are 
CD8 +  tx/B  TCR +  (50-60%),  CD4 +  a//3-TCR +  (20- 
30%), and CD4-8-  y/tS-TCR + (5-10%), whereas there are 
very few B cells. The numbers of CD4 + and CD8 + T cells 
in the MLN are approximately equivalent, with <5% 3'/t~ 
T  cells and large numbers of B lymphocytes (7,  8,  15). 
Kinetics of Cytokine Gene Expression in the Primary and Sec- 
ondary Response.  The  first  experiments  concentrated  on 
mRNA  for cytokines characteristic of CD8 +  and CD4 + 
TH1 (IL2 and IFN-3,) and the CD4 + TH2 (IL4 and IL-10) 
subsets.  The patterns of cytokine production in MLN and 
NA BAL populations for primary infection with the HKx31 
virus (Fig.  1, A  and B) are very much in accord with the 
idea that the initial events in this virus-specific immune re- 
sponse are occurring in the regional MLN,  where there is 
little evidence of virus replication (25),  rather than in the 
target organ (the lung) that supports maximal virus growth. 
Profiles of cytokine mRNA expression similar to that shown 
for the MLN might, of course, be found in the bronchus- 
associated lymphoid tissue,  but this has not been analyzed 
in the present experiments. The divergence between the BAL 
and MLN is much less apparent for the more rapid secondary 
response (Fig.  2, A  and B). 
Expression of mRNA for IL-2, IL-4, and IFN-y is in no 
sense mutually exclusive, at least at the cell population level, 
with transcripts for all three cytokines being prominent as 
early as day 3 in the primary response (Fig.  1 A). The fre- 
quency of cells with IL-10 mRNA is generally lower in the 
MLN than in the BAL, and increases with time in the BAL 
(Figs.  1 B and 2 B). The greater prevalence of all mRNA + 
cells in the BAL on days 10 and 13 after primary infection 
(Fig.  1 B) could reflect ongoing processes  after the virus is 
cleared (day 7 or 8),  or simply the retention of activated, 
cytokine mRNA + lymphocytes in the inflammatory exudate 
during the period when cell numbers decline (Fig. 1 B). There 
is, however, an increase in both the total numbers and per- 
centage of cytokine mRNA + BAL cells between days 5 and 
7 of the secondary response (Fig.  2 B). 
Evidence of substantial transcriptional activity is,  there- 
fore,  found for all  the cytokines tested.  The  numbers  of 
mRNA + cells in the regional LN are maximal at the early 
stages after challenge, and then decline as the inflammatory 
process develops in the lung. This difference is most apparent 
for the slower,  primary response. 
The y/c~-TCR + Lymphocytes.  The NA BAL population 
was separated using the FACS  |  into c~/{3-TCR + and "y//i- 
TCR + subsets  (Table 1). The percentage of cells expressing 
mRNA for IL-4, ILl0, IFN-'y, and TNF-~ was two to three- 
fold higher  for the "y/t~-TCR + population  than  that  ob- 
served for the oEfl-TCR § population, both on day 10 after 
primary infection and on day 7 after secondary challenge. Sub- 
stantial percentages of I1.-2 (45%),  IFN-'y (49%),  and IL-6 
(18%) mRNA + 3,/t5 T cells were also found in the BAL on 
day 10 of the primary response.  In addition,  the mRNA 
profiles for FACS|  3~/& T cells from the MLN were 
analyzed on days 5 and 7 after i.n.  exposure of naive mice 
to the HKx31 virus: from 15 to 20% of the 3,//} T cells ob- 
tained on day 7 expressed mRNA for IL-2, IL-4, or IFN-3, 
(3'/&TCR +,  Fig. 3).  The relative frequency of IL-2, IL-4, 
and IFN-3' mRNA + lymphocytes was highest for the o~/B- 
TCR + population on day 5 and for the 3,/~-TCR + set on 
day 7 (Fig.  3). 
This analysis establishes that there is substantial activation 
of cytokine genes in 3'/t~ T cells recovered from both the BAL 
477  Carding et al. O 
< 
z 
nr- 
E 
40 
20 
0 
40 
20 
0 
40 
20 
0 
60 
40 
20 
0 
-IL4 
I L10 
-TCRa 
0  3  5  7 
4OtlFN-7 
2o 
4o~ TNF/J 
6~ t TCRd 
0  3  5  7 
Days  after  i.n.  infection 
[]  yd TCR  + 
[] eflTCR + 
[]  a,  fl+CD4 ~ 
[] o~/3*CD8* 
￿9  No  sample 
Figure  3.  The prevalence of cytokine mRNA expression 
in different lymphocyte subsets is shown for the first 7 d of 
the primary response in the MLN to the HKx31 virus. The 
cells were separated in two-color mode using PE-conjugated 
antiffCR-~ versus FITC-conjugated anti-TCR-/i, CDS,  or 
CD4. There were insuf~cient 3'/~ T cells to analyze on day 
0, or for some cytokines on day 3. The CD4 + T cells from 
day 5 were lost because of a technical error. 
and the MLN, with the percentage of mRNA + cells often 
exceeding that found for the cffB-TCIL + population. How- 
ever, by FACS  |  phenotyping,  the CD4-8-  3//~ T cells are 
much  less  prevalent in  both  sites than  the  conventional 
CD4 + and CD8 + subsets (15). The majority of the T lym- 
phocytes expressing lymphokine  mRNA in both the MLN 
and the BAL are thus o~/B T  cells. 
The  CD4 +  and  CD8 +  c~/fl  T  Cells.  The  mRNA 
profiles for FACS|  CD8 + &B-TCR + and CD4 + 
&B-TCR +  MLN  cells  from  the  primary  response  are 
presented in Fig. 3. The frequency of IFN-3~ mlLNA + MLN 
cells was lower  on day 7  (compared with  day 3)  for both 
the  CD4 +  and  CD8 +  subsets,  whereas  the  percentage  of 
CD4 § lymphocytes with IL-4 and II.-10 transcripts had in- 
creased (Fig.  3). This could reflect the emergence of a TH2 
response.  The  percentage  of CD8 +  T  cells  with  TNF-/~ 
transcripts  increased  with  time (Fig.  3). 
The NA BAL cells were .analyzed using both FACS  |  and 
the MACS separation procedures (Fig. 4, Table 2). Previous 
studies (15) have shown that some activated T  cells are nor- 
mally gated-out (because of autofluorescence and nonspecific 
staining)  in a  high 90 ~  scatter,  or side scatter  (HSSC),  set 
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Figure 4.  The cytokine mR.NA profiles in the NA BAL 
are shown on days 7-13 of the primary response, for the same 
experiment as in Fig. 3. 
478  Cytokine mP,  NA Profiles in a Viral Pneumonia Table  2.  Expression of mRNA  in  CD4 + and  CD8 + T  Cells 
Enriched from Nonadherent BAL Populations Using the MACS 
Primary  Secondary H1NI~H3N2 
Day  10  H3N2  Day 3  Day 5 
mRNA  CD4 +  CD8 +  CD4 +  CD8 §  CD4 +  CD8 + 
IL-2  32*  49  13  19  39  41 
IL-4  26  7  24  6  42  10 
IL-6  10  3  11  21  20  11 
IL-10  24  2  21  8  13  8 
IFN-y  12  10  3  25  11  69 
TNF-~  3  19  14  17  15  46 
TCR-~  73  69  72  79  84  71 
TCR-~  11  16  12  15  11  13 
* Results are expressed  as percent  mRNA + cells. 
it is likely that some large, responding o~/B and 7/6 TCR + 
lymphocytes were excluded. On the other hand, the MACS 
separation procedure is probably less precise. 
Despite the various technical limitations and quantitative 
differences, the FACS  |  and MACS-sorting experiments with 
these highly activated BAL populations generally showed the 
same trends (Fig.  4,  Table 2).  Evidence of substantial Ib4 
and  I1:10  transcription  was  found mainly for the CD4 + 
subset. Cells with mRNA for IFN-3~ and TNF-B are more 
commonly found in the CD8 §  population.  The CD4 + T 
cell response might seem to be skewed towards a TH2 profile 
(1),  if it were not for the fact that many of the CD4 + T 
cells  isolated on the MACS expressed I1:2  mRNA  (Table 
2).  The  percentage  of IFN-y  mRNA +  CD8 +  and  I1:4 
mRNA + CD4 + BAL T cells was very high at the peak of 
the secondary response on day 5 (Fig.  2, Table 2).  It seems 
very unlikely that the majority of these lymphocytes could 
be responding specifically to the virus (2). Perhaps this reflects 
that the cytokine-rich milieu of the inflammatory exudate 
induces transcriptional activity in a broader spectrum of T cells. 
that constitutes a minority of the NA BAL cells from day 
5 of the secondary response. Determining cytokine mRNA 
profiles for secondary NA BAL cells sorted on the basis of 
low SSC (LSSC) or HSSC showed that the HSSC set con- 
tained many cells with the morphology of activated (or effete) 
macrophages (15), which might be expected (26, 27) to pro- 
duce TNF  and I1:6.  In addition  to  the expression of the 
genes encoding these cytokines, there were also substantial 
numbers of HSSC cells expressing mRNA for II:2, I1:4, and 
IFN-3' (Fig.  5).  In the analysis  of cytokine production by 
T cell subsets for FACS|  BAL populations, therefore, 
Discussion 
Analysis of cytokine mRNA profiles, often determined by 
semiquantitative  approaches  using  the PCR,  is  a  feasible 
method for assessing the involvement of these mediators in 
inflammatory processes (28, 29).  However, PCR analysis of 
tissue samples does not localize the distribution of cytokine 
production within populations of cells, and gives no insight 
into the relative proportion that are expressing the message. 
The in situ hybridization approach overcomes these limita- 
tions of PCR analysis  (11, 12), and has the advantage that 
the patterns determined are not subject to modification by 
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Figure 5.  The NA BAL populations  from secondarily- 
stimulated mice were separated into high and low side-scatter 
populations  with the FACS  |  (13). The LSSC set is charac- 
teristically used for FACS  |  phenotyping and sorting lympho- 
cyte subsets. The percentage of cells in these two populations 
on days 3, 5, and 7 were: LSSC, 30, 49, and 59; HSSC, 31, 
14, and 13. The highly granular NK cells would be promi- 
nent in the HSSC set during the early phases of the response. 
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or during the process of sampling. 
The correlation between cytokine gene expression and 
cytokine release is complex. Detection of cytokine mRNA 
in freshly isolated cells is obviously a very sensitive measure 
of lymphocyte activation in vivo. However, the presence of 
message is not a measure of the synthesis and secretion of 
active protein. Given that individual mRNA + cells are likely 
to produce more or less of a particular cytokine, we cannot 
say how well the mRNA profiles are likely to correlate with 
the level of functional activity. Even so, the utility of in situ 
hybridization for analyzing the kinetics of an in vivo immune 
response to a pathogen is clearly demonstrated by the present 
lymphocyte subset analysis. 
The first obvious change in the primary response to an 
influenza A virus given i.n. is the massive increase in the cel- 
lularity of the regional MLN. This occurs in the absence of 
significant virus replication in this site (25).  At least 15% 
of these LN cells are expressing I1-2 and/or IFN-3, mR.NA 
within 3 d  of the infection. Transcripts are found in both 
CD4 + and CD8 + u/3 T cells, though the CD4 + set seems 
to assume more of a THz phenotype later in the response. 
It seems very unlikely that one in seven of the cells in the 
MLN at day 3 is responding specifically to the virus. Some 
of this IFN-3' mRNA may be expressed in NK cells, which 
are prominent in the early stages of the host response to most 
viruses and may be induced by cytokines produced by virus- 
infected cells. Draining lymph from the virus-infected lung 
is, for example, likely to contain IFN-ol/3 which has been 
shown (in other experimental systems) to cause early LN en- 
largement (30,  31). 
The divergence in the prevalence of cytokine mRNA § 
cells for the MLN (early) and BAL (late)  seen for the pri- 
mary response is less obvious after secondary challenge. This 
could simply reflect that the kinetics of the secondary response 
are much more rapid. However, it might also indicate that 
virusqmmune memory T cells, which are more readily trig- 
gered to effector function (32), are less dependent on the LN 
environment for stimulation. Recent studies (33) indicate that 
trafficking through lymphoid tissue is characteristic of naive 
rather than memory T  cells. 
Transcriptional activity for I1-10, the cytokine thought to 
be involved with downregulation (4, 34) of many aspects of 
immunity, is dearly prominent in the later stages of the inflam- 
matory process during the primary response, reaching max- 
imal prevalence on day 10, 2-3 d after infectious virus is cleared 
from the lung (7). Expression of I1-10 mRNA was mostly, 
though not exclusively, associated with the CD4 + and 3'/6- 
TCR + subsets. However, I1-10 mRNA + cells were also very 
evident in the early stages of the secondary pneumonia, which 
may indicate that memory CD4 + TH2 cells are being pref- 
erentially induced. 
These experiments further indicate that the 3'/6 T  cells 
are an active component of influenza pneumonia (14, 35). 
This lymphocyte subset showed, at the different time points 
tested, evidence of transcription for all cytokines analyzed. 
Perhaps the role of the 3'/~ T cells in this virus-induced inflam- 
matory process is to act as cytokine factories which may, for 
instance, help to regulate macrophage activation and other 
essentially nonspecific effector mechanisms (4,  35,  36). 
The present in situ hybridization analysis provides a spec- 
trum of insights that will greatly facilitate the further dissec- 
tion of this experimental system. For instance, there is no 
lack of transcriptional activity for the conventional T cell lym- 
phokines in this nonfatal pneumonia, though experiments 
measuring cytokine levels in a lethal influenza infection did 
not indicate significant T cell involvement (10). The two sit- 
uations need to be compared using the same technical ap- 
proaches,  to  see if differences in  lymphokine profiles  are 
influencing the clinical  outcome. Questions are raised con- 
cerning the relative significance of the TH1 and TH2 CD4 + 
subsets.  Separated CD4 + T  cells in both the primary and 
secondary response showed mIkNA profiles more character- 
istic of TH2 cells, though many of the CD4 + T cell clones 
recovered from influenza virus-infected mice have the TH1 
cytokine phenotype (T. J.  Braciale,  personal communica- 
tion; 37). 
It is also apparent that we need to consider activation mech- 
anisms that do not depend on the engagement of the antigen- 
specific TCR, particularly in sites of inflammatory pathology. 
Many more T cells show evidence of transcriptional activity 
than would be expected to be responding specifically to the 
virus (2, 6, 7). Even so, the mRNA expression profiles de- 
scribed here are generally in accord with current thinking 
concerning the cellular origins and biological role of partic- 
ular cytokines (1, 3,  4). 
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